BRIAN GAYNOR: The rise and rise of Fisher & Paykel Healthcare

BRIAN GAYNOR: The rise and rise of Fisher & Paykel Healthcare
Brian Gaynor
Fisher & Paykel Healthcare has been a fantastic investment in recent years, particularly during the covid-19 pandemic.At the end of June, the medical supplies company had a share market value of $20.5 billion, making it the first $20 billion NZX company. Its performance during the covid-19 crisis has been amazing with its total market value surging $7.1 billion between Jan. 31 and June 30. This value accretion was greater than the total value of all but four other NZX listed stocks: A2 Milk, Meridian Energy, Auckland International...

More Opinion

What soft housing demand signals for NZ’s economy
Opinion

Cameron Bagrie: What soft housing demand signals for NZ’s economy

The country’s population slowdown has left housing supply outpacing demand.

War on the Nasdaq
Opinion

Simon Robertson: War on the Nasdaq

Who wins as Michael Burry declares war on AI?

Simon Robertson 08 Nov 2025
War on Nature v Going for Growth
Opinion

Pattrick Smellie: War on Nature v Going for Growth

Some big environmental eggs were broken this week to 'go for growth'.

Pattrick Smellie 07 Nov 2025
A blueprint to beat our economic malaise
Opinion

Peter Griffin: A blueprint to beat our economic malaise

NZ must trade talk for execution and invest in talent to escape its economic woes. 

Peter Griffin 05 Nov 2025